Pro Dex (PDEX) Total Non-Current Liabilities (2013 - 2026)
Pro Dex (PDEX) reported Total Non-Current Liabilities of $15.1 million for Q1 2026, up 41.87% on a YoY basis from $10.7 million in Q1 2025, and up 79.76% sequentially from $8.4 million in Q4 2025.
Pro Dex (PDEX) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Pro Dex (PDEX) has 11 years of Total Non-Current Liabilities data on file, last reported at $15.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities rose 41.87% year-over-year to $15.1 million; the trailing twelve-month figure through Mar 2026 stood at $15.1 million (up 41.87% YoY), and the FY2025 full-year result was $9.9 million, up 13.91% from the prior year.
- Total Non-Current Liabilities climbed to $15.1 million in Q1 2026, from $8.4 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $15.1 million in Q1 2026 to a low of $8.4 million in Q4 2025.
- A 5-year average of $10.9 million and a median of $10.7 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities retreated 26.19% in 2025 and soared 41.87% in 2026, its largest moves.
- Tracing PDEX's Total Non-Current Liabilities over 5 years: stood at $11.4 million in 2022, then dropped by 15.64% to $9.7 million in 2023, then increased by 18.26% to $11.4 million in 2024, then declined by 26.19% to $8.4 million in 2025, then soared by 79.76% to $15.1 million in 2026.
- Business Quant data shows PDEX's Total Non-Current Liabilities at $15.1 million in Q1 2026, $8.4 million in Q4 2025, and $9.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Pro Dex | 174.76 Mn | 165.70 Mn | 6.13 Mn | 15.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.14 Mn |
| Dec 31, 2025 | 8.42 Mn |
| Sep 30, 2025 | 9.18 Mn |
| Jun 30, 2025 | 9.93 Mn |
| Mar 31, 2025 | 10.67 Mn |
| Dec 31, 2024 | 11.41 Mn |
| Sep 30, 2024 | 12.15 Mn |
| Jun 30, 2024 | 8.72 Mn |
| Mar 31, 2024 | 9.19 Mn |
| Dec 31, 2023 | 9.65 Mn |
| Sep 30, 2023 | 10.11 Mn |
| Jun 30, 2023 | 10.56 Mn |
| Mar 31, 2023 | 10.99 Mn |
| Dec 31, 2022 | 11.44 Mn |
| Sep 30, 2022 | 11.88 Mn |
| Jun 30, 2022 | 12.30 Mn |
| Mar 31, 2022 | 13.89 Mn |
| Dec 31, 2021 | 14.14 Mn |
| Sep 30, 2021 | 14.27 Mn |
| Jun 30, 2021 | 13.97 Mn |